Futura Medical plc (Futura) develops products for the consumer healthcare market. The Company�s principal activity includes research and development of medical devices and pharmaceutical drugs and their commercial exploitation with the focus being on transdermal products for sexual healthcare and pain relief management. Futura�s sexual healthcare products included CSD500, PET500 and MED2002. Its pain relief management included TPR100 and TPR100-Rx. Futura has developed a transdermal delivery technology, DermaSys, for the absorption of active molecules through the skin. CSD500 is aimed at helping men maintain a firmer erection during intercourse whilst wearing a condom. MED2002 is a topical gel for the treatment of male erectile dysfunction. TPR100 is a product for the provision of topical pain relief. TPR100-Rx is a topical product available on prescription for the treatment of more profound indications, such as osteoarthritis and rheumatic pain.